21/07/2026
The people with the lowest cardiometabolic risk are not the ones who avoid coffee. They are the ones who drink a moderate amount of it.
In the largest data we have, about three cups a day tracked with the lowest risk of developing diabetes, heart disease, and stroke together, and moderate drinkers came in well below people who drank none.
In 188,000 UK adults who were free of cardiometabolic disease at the start, moderate coffee drinkers, around three cups a day, had roughly 48 percent lower risk of later developing cardiometabolic multimorbidity, meaning two or more of type 2 diabetes, coronary heart disease, and stroke at once. Measured by caffeine instead of cups, 200 to 300 milligrams a day showed the same pattern at about 41 percent lower. The protective direction held even in people who already had one chronic disease, where up to three cups a day tracked with a lower risk of progressing to a second.
The metabolites that statistically linked coffee to lower risk included lipids carried in very-low-density lipoprotein, the amino acid histidine, and glycoprotein acetyls, a marker of low-grade inflammation. Coffee is not a single compound. It shifts several of the systems that drive cardiometabolic disease, and these studies could see those changes in the blood. Both analyses were independently funded and reported no industry ties, which is not a given in coffee research.
The benefit was greatest in the middle and did not grow with heavier intake. Past about five cups a day the association faded, and in people who already had a chronic disease it edged toward higher risk instead of lower. This is not a reason to worry about a normal coffee habit. It is a reason not to treat coffee as something to load up on, because the advantage lives in moderation rather than in volume.
How much the upper end matters depends partly on your genes. Among the heaviest drinkers, people who clear caffeine slowly saw the high-intake risk rise most, while fast metabolizers were far less affected. Caffeine clearance is partly inherited, so the point where more coffee stops helping sits in a slightly different place for different people. For most, this is academic, because a moderate habit stays comfortably below any of these thresholds.
These are observational studies, which show association rather than proof. They cannot say coffee itself lowered anyone's risk, since people who drink a moderate amount may differ from those who drink none or a great deal in ways that also shape health. What they can say is consistent and worth knowing: across very large populations, the lowest cardiometabolic risk lined up with moderate coffee, and it showed up whether people were healthy or already managing a condition.
If you enjoy coffee, the data is reassuring. Roughly one to three cups a day is squarely where the lowest risk sat. You do not need to cut it back, and there is nothing to gain by pushing it higher. In moderation, coffee tracks with some of the lowest cardiometabolic risk in the population, and that is a rare thing to be able to say about something people already enjoy.
Moderate coffee, about three cups a day, tracked with the lowest cardiometabolic risk, in healthy people and in those already managing a chronic disease. The benefit sits in moderation, not in more.
PMID 39287934.
PMID 40947393.
